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Dear Dr. Ojcius,  
 
 
On behalf of my co-authors, I would like to submit our meeting report “Symposium report: One 
Health meets sequencing” to Microbes and Infection.  
 
The Whole Genome Sequencing technology has revolutionized the way epidemiology is performed 
in a very rapid way. The technology’s potential has not been explored in “One Health” related 
questions in full detail – beside technical aspects also ethical aspects are crucial. Therefore we have 
organized a symposium on this technology with a focus on current and future applications in the field 
of “One Health”.   
 
This review article summarizes the various talks held during the symposium. We confirm that the 
material is based on the workshop. Neither the work nor any part of its essential substance, tables 
or figures have been published or submitted to another scientific journal or is being considered for 
publication elsewhere. The authors conflicts of interest are outlined in the manuscript. All authors 
read the final submitted. 
 
Yours sincerely, in behalf of all co-authors 
 
 
 
Adrian Egli, MD PhD 
Head of Division, Clinical Microbiology 
University Hospital Basel, Switzerland 
Cover Letter
Title: 
Symposium report: One Health meets sequencing 
 
Authors: 
Adrian Eglia,b,+, Daniel Kochc, Jürg Danuserd, Rene S Hendriksene, Susanne Driesenf, Diana 
Coman Schmidg, Richard Neherh,i, Mirjam Mäusezahlc, Helena MB Seth-Smitha,b,h. Guido 
Bloembergj, Sarah Tschudin-Sutterk, Andrea Endimianil, Vincent Perretenm, Gilbert Greubn, 
Jacques Schrenzelo, Roger Stephanp 
  
Affiliations: 
a Clinical Bacteriology and Mycology, University Hospital Basel, Basel, Switzerland 
b Applied Microbiology Research, University of Basel, Basel, Switzerland 
c  Federal Office of Public Health, Liebefeld, Switzerland 
d Federal Food Safety and Veterinary Office, Bern, Switzerland 
e National Food Institute, Technical University of Denmark, Denmark 
f swissethics, House of the Academies, Berne, Switzerland  
g Scientific IT Services, ETH Zurich, Zurich, Switzerland 
h Swiss Institute of Bioinformatics (SIB), Basel, Switzerland 
i Biozentrum, University of Basel, Basel, Switzerland 
j National Center for Enteropathogenic Bacteria and Listeria (NENT), Institute for Food Safety 
and Hygiene, University of Zurich, Zurich, Switzerland 
k Infectious Diseases and Hospital Epidemiology, University Hospital Basel and University of 
Basel, Basel, Switzerland 
l Institute for Infectious Diseases, University of Bern, Bern, Switzerland 
m Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Bern, Bern, Switzerland 
n Institute of Microbiology, University Hospital Lausanne, Lausanne 
o Bacteriology and Genomics Research Laboratories, University Hospital Geneva, Geneva, 
Switzerland 
p Institute for Food Safety and -hygiene, Vetsuisse Faculty, University of Zurich, Zurich, 
Switzerland 
 
all authors have equally contributed to this paper. 
 
+ Corresponding author:  
Adrian Egli, MD PhD 
Clinical Bacteriology & Mycology 
University Hospital Basel 
Main Manuscript Click here to view linked References
Petersgraben 4 
4031 Basel 
adrian.egli@usb.ch 
 
Short title: One Health meets sequencing 
Keywords: One Health, Switzerland, whole genome sequencing, metagenomics, regulation, 
data protection, ethics, legal, perspectives, data sharing, food borne pathogens, transmission, 
environment 
Funding: The symposium was funded by the Swiss National Science Foundation – NRP72 on 
antibiotic resistance. 
 
  
Abstract: 
 
Whole genome sequencing (WGS) has become the new gold standard for typing and 
characterization of pathogens. WGS enables understanding transmission chains of bacteria, 
exchange of mobile genetic elements, and variation in viruses with the highest resolution. In 
the near future, national and international databases will allow the tracking of pathogen 
transmissions based on WGS data in and across complex settings such as humans, animals, 
food, water and other environmental sources. Understanding the complexity and dynamics of 
and across these compartments will also help us to reduce transmissions of multi-drug 
resistant pathogens.  
Several important challenges for Public Health and One Health-related questions need to be 
identified such as defining standards for data analysis, accessing important epidemiological 
metadata, sharing data sharing while respecting data protection and ethical considerations. 
This symposium brought together leading institutions and fostered the ongoing discussion on 
the identified challenges, paving the way for solutions in public health, diagnostics, and 
research. This symposium report summarizes the key messages. 
 
  
Introduction 
According to the World Health Organization (WHO), One Health is an approach to design and 
implement programs, policies, legislations, and research in which multiple aspects of the 
interactions of humans, animals, food, and the environment are interconnected 
(https://www.who.int/features/qa/one-health/en/). These aspects have a particular relevance 
for food safety, control of zoonoses and antibiotic resistance (1-3). Many microbes can infect 
or colonize various compartments forming a complex interplay between humans, animals and 
the environment (4). Efforts focusing on a single aspect cannot prevent or eliminate the 
problem. Information sharing is key and multiple examples exist show-casing this e.g. drug-
resistant bacteria can be transmitted through direct contact between animals and humans or 
through the food chain. In order to effectively detect, respond to, and prevent transmission 
events, zoonoses and food safety issues, epidemiological and laboratory/microbiological data 
have to be shared across stakeholders. Experts in the fields of microbiology, epidemiology, 
infectious diseases, veterinary, and public health should form local, national, regional and 
global networks to link the responses of these highly important public health threats.  
A key element in approaching the challenges of One Health includes generating high 
resolution spatio-temporal data on pathogens together with genomic relatedness of pathogens 
(5). Whole genome sequencing (WGS) has become the new gold standard for typing and 
further characterizing of pathogens. WGS enables understanding transmission chains of 
bacteria, exchange of mobile genetic elements, and variation in viruses with the highest 
resolution. In the near future national and international databases will allow tracking pathogen 
transmissions based on WGS data in and across complex settings such as humans, animals, 
food, water and other environmental sources (6-10).  
 
Participants 
The symposium attracted more than 90 participants and faculty members with a key interest 
in the fields of One Health and WGS. The one-day symposium was held on the 21st of May 
2019 in Lucerne, Switzerland, and covered a broad diversity of topics in four sessions: (i) 
perspectives on WGS, (ii) ethics, data protection, and data sharing, (iii) foodborne pathogens, 
and (iv) transmissions from animals and the environment to humans. Finally, in a round table 
discussion the requirements and next important steps for “One Health and sequencing” were 
addressed. These topics and aspects were covered by leading experts in their field of One 
Health, public health, epidemiology, microbiology, infectious diseases, and ethics. The 
workshop was organized and hosted by the Clinical Bacteriology and Mycology of the 
University Hospital Basel (Dr. Adrian Egli), Clinical Bacteriology of the University Hospital 
Geneva (Prof. Jacques Schrenzel), and the Institute for Food Safety and -Hygiene of the 
University of Zurich (Prof. Roger Stephan). The symposium was sponsored by the National 
Research Program 72 (www.nrp72.ch/en). During breaks, there were opportunities for 
networking and fruitful discussions about new ideas and innovative past and future studies in 
the field of “One Health”. 
 
 
Session I: Perspectives on Whole Genome Sequencing 
In the first session of the symposium, perspectives from regulatory federal offices (Federal 
Office of Public Health and Federal Food Safety and Veterinary Office) were summarized and 
discussed by Dr. Koch and Dr. Danuser. Key points included the mindful usage of new 
technologies, involvement and interactions with reference laboratories. In the keynote lecture 
Prof. Hendriksen addressed the global connection of animals, food, environment, and 
humans. He showcased the power of metagenomic approaches in sewage samples. 
 
Federal Food Safety and Veterinary Office FSVO (Jürg Danuser) 
The nucleus of One Health is an integrative collaboration of human and veterinary medicine. 
Today not only physicians and vets are One Health agents, but experts from agriculture, 
food, environment and other disciplines as well. One Health implies an agreement between 
sectors on super ordinated goals and on measures to be taken. Using a One Health 
approach, we aim to generate additional value in terms of better health of humans and 
animals, in terms of saving resources and in terms of a positive impact on the environment. 
Zoonoses, vector borne diseases, antimicrobial resistance are main One Health issues. With 
the Epidemic act (11) a coordinating platform was established, the so-called subsidiary body 
One Health. It coordinates the cooperation of the concerned sectors in the confederation and 
the cantons. As sequencing is a key technology to characterize public and animal health 
threads it suits well to the One Health approach.  
In the competence of the FSVO sequencing plays or will play an important role in controlling 
foodborne diseases, in monitoring of antimicrobial resistance in food and healthy food 
producing animals, and in eradication of epizootic diseases. Introducing WGS should be 
coordinated among the stakeholders in different sectors and with respect to European 
standards. 
 
 
Usage of WGS to address one health challenges (Rene S. Hendriksen) 
The dynamics of common infectious diseases are changing with the world heading towards 
an era of emerging and re-emerging infectious diseases where antimicrobial resistance 
threatens the very core of modern medicine and the sustainability of an effective, global public 
health response. Due to the complexity of the problems, there is a need for a harmonized and 
immediate action setting up surveillance. 
From a surveillance point of view, sewage as well as animal wastewater are attractive matrices 
because it combines material from a large and mostly healthy population, which would 
otherwise not be feasible to monitor. Metagenomic sequencing of sewage and wastewater as 
well as quantification of antimicrobial resistance genes and residues combined with 
epidemiological data is a possible way to determine the occurrence and burden of resistance 
in defined healthy populations. 
Recent developments in high‐throughput sequencing offer the ability to rapidly identify nucleic 
acids from various organisms in clinical and environmental samples and provide a much 
broader resolution than offered by current methodologies. Thus, we launched a Global 
Sewage Surveillance study, collecting urban sewage from 77 cities across 63 countries 
including all inhabited continents. Our findings suggest that global AMR gene diversity and 
abundance vary by region and are caused by national circumstances. Improving sanitation 
and health could potentially limit the global burden of antimicrobial resistance (8). 
 
Session II: Ethics, data protection and data sharing 
In the second session of the symposium, various aspects of data collection, data sharing, and 
data protection were discussed. Platforms and incentives to share sequence and 
epidemiological data were discussed by Dr. Egli and Prof. Neher. Basic and practical aspects 
of data protection and sharing were discussed by Dr. Coman Schmid. The legal and ethical 
framework in Switzerland was discussed by Dr. Driessen.  
 
Overview on a Swiss Pathogen Surveillance Platform (Adrian Egli) 
Multidrug resistant (MDR) bacteria are one of the most urgent public health threats for our 
society. The spread of MDR bacteria can be described and analysed using high-resolution 
molecular typing technologies, such as WGS. WGS data can be fused with spatiotemporal 
epidemiological and demographic patterns thereby allowing explain transmission events and 
outbreaks at different scales (12, 13). However, the data from human, animal, food, and the 
environment are fairly complex and often not structured. Interoperable and curated 
epidemiological metadata is a key requirement to fully understand the “One Health” 
complexity. In addition, high quality sequence data is crucial for epidemiological applications. 
We aim to build a Swiss wide Surveillance platform to enable the collection, storage, analysis 
and interpretation of “classical” epidemiological data together with molecular epidemiological 
data based on WGS from pathogens (5). The development of the platform is funded by the 
NRP72 from 2018 to 2020 (www.nrp72.ch) and we have achieved to develop a first prototype 
which was introduced (www.spsp.ch). The platform has a state-of-the-art backend 
bioinformatics and frontend visualization tools including phylogenies, maps and various 
project management features. After the proof of concept with methicillin resistant 
Staphylococcus aureus, the idea is to expand the platform to a broad spectrum of pathogens 
and antibiotic resistant bacteria, including food- and water-born bacteria and many other 
pathogens. 
 
Ethical and legal requirements for surveillance (Susanne Driessen) 
The presentation focused on basic ethical concepts including deontology and 
teleology/utilitarism and links them to the four bioethical principles beneficence, non-
maleficence, justice, and autonomy. Social benefit, scientific validity, a favorable risk benefit 
ratio, as well as an informed consent are additional key ethical requirements for human 
research. The basis with the Human Research Act (HRA; www.swissethics.ch (14)) provides 
the legal framework in Switzerland whenever research with persons or projects involving 
further use of health-related data or biological material is done. The purpose of the HRA is the 
protection of dignity, privacy and health of the individuals within research. The main focus for 
the One Health approach is the demarcation of surveillance and bacterial genetics within the 
HRA: WGS in bacterial genetics per se does not fall under the scope of the HRA. However, 
whenever there is a linkage to coded health-related data the HRA applies and consent of the 
individuals is foreseen. Specific consent versus general consent apply depending on the 
hierarchism of coding versus anonymization and the implication of genetic versus non-genetic 
data. Finally, ongoing efforts regarding the implementation of ethical frameworks in the One 
Health approach were discussed. 
 
Data protection of medical data (Diana Coman Schmid) 
Research biomedical data from patients is sensitive personal data (also referred to as 
confidential data) and it requires special data and computing infrastructure services that blend 
three major concepts: a) security and compliance, to protect the research subjects' privacy, b) 
scalability and performance and c) flexibility and usability, to foster cutting-edge biomedical 
research.  
Leonhard Med (https://sis.id.ethz.ch/), operated by the Scientific IT Services of ETH Zurich is 
one of the first such infrastructures being developed in Switzerland. Built as a security by 
design infrastructure, Leonhard Med is a high-performance research platform to securely 
store, manage, compute on and share confidential research data and support data driven 
biomedical research at ETH and at national level, as part of the emerging national BioMedIT 
network supporting projects in the Swiss Personalized Health Network (SPHN; www.sphn.ch). 
Using secure IT infrastructures when working with confidential data requires awareness of 
data privacy, respective laws and information security. When to use such secure 
infrastructures? Whenever the research data is confidential. Research data may classify as 
confidential (based on the SPHN IT Security Policy (15) and on the Leonhard Med Acceptable 
Use Policy) if: (i) it is sensitive personal data (Federal Act on Data Protection, FADP Art. 3c 
(16)), for example health-related or medical data, (ii) it is either identifying (directly or indirectly) 
or pseudonymized (i.e., real name replaced by a code) or (iii) more generally, it is information 
that is specific to a limited, explicitly defined group of recipients. However, data classification 
is not always straightforward. Given the potential of re-identification (17) should the human 
gut microbiome data classify as confidential even though only bacterial species information is 
contained?  
In the dynamic fields of Precision Medicine, Personalized Health and One Health, controlled 
and secure handling and sharing of confidential data, according to the FAIR principles 
(Findable Accessible Interoperable Re-usable), must be embraced for facilitating scientific 
advancement. For this, the pioneering work on building secure research platforms and 
developing security awareness training programs should continue in the collaborative 
academic, medical, ELSI and IT ecosystem. 
 
Incentives for WGS data sharing (Richard Neher) 
Detecting outbreaks and transmission clusters requires dense sampling and the ability to 
integrate data from different stakeholders. For such detection of transmission to have impact, 
it needs to be timely. 
Universal and rapid data sharing of epidemiological and pathogen genomic data is therefore 
imperative. Balancing this need with privacy concerns and the particular interests of scientists 
and institutions has been a recurring struggle in past outbreaks of viruses like the West African 
Ebola virus outbreak (18, 19). Some communities such as the GenomeTrakr network (20) or 
the Global Influenza Response and Surveillance System (21) have successfully established 
data sharing mechanisms, while other communities remain fragmented. Such fragmentation 
hampers our ability to combat transmission. The emphasis should be on near universal open 
sharing of genome sequences, with meta data restricted where necessary. Tools and 
platforms that facilitate tracking of transmission and integrate data can provide important 
incentives for data sharing. 
   
Session III: Foodborne pathogens 
In the third session various examples of foodborne pathogen transmission were discussed. 
Dr. Mäusezahl provided an overview on foodborne pathogens in Switzerland – highlighting 
the dynamic changes and the challenges in streamlining the notification process. This was 
followed by presentations focusing on Campylobacter spp. and Salmonella spp. – the two 
most common bacterial pathogens associated with gastrointestinal infections in Switzerland 
by Dr. Seth-Smith and Dr. Bloemberg. Finally, Prof. Tschudin reported on the spread of ESBL-
producing Enterobacteriaceae and a NRP72 funded project aiming to understand the complex 
transmission dynamics.  
 
Foodborne pathogens in Switzerland (Mirjam Mäusezahl) 
The surveillance and control of foodborne pathogens is a classic One Health topic where 
interdisciplinary collaboration is key for success. The surveillance objectives for foodborne 
diseases in Switzerland are the early detection and investigation of outbreaks to identify 
sources of infection and prevent new infections as well as the analysis of long-term trends to 
assess food safety measures put in place. Notifications of foodborne diseases in humans are 
increasing for some pathogens such as Listeria, Campylobacter and Shigatoxin-producing E. 
coli (STEC) and stay at a long-term high level for others such as Campylobacter spp. However, 
it must be kept in mind that notified cases only represent the tip of the surveillance pyramid. 
In addition, the risk for large cross-border outbreaks increases due to the increasingly 
globalized food production and distribution chains. There is a multitude of players involved in 
outbreak investigation and management at the national as well as cantonal level and three 
different legislative acts (Federal Act on Epidemics, Foodstuffs and Utility, and Animal 
epidemics (11, 22, 23)) build the basis of all activities. While classical outbreak investigation 
involves patient interviewing paired with pathogen identification and comparison of human and 
food samples at the reference laboratory level, WGS enhances microbiological resolution and 
the level of “evidence” in case of a match. The main challenges remain to streamline 
notification processes and the matching of isolates between the human and foodstuff sector 
including creating the legal framework and to use WGS wisely, as costs are still relatively high. 
 
Campylobacter spp. always from chicken to men? (Helena MB Seth-Smith) 
Campylobacter causes a high burden of disease and cost in Switzerland, and globally (24, 
25). The species Campylobacter jejuni and Campylobacter coli are responsible for the majority 
of cases. Cross contamination on kitchen level is thought to be the main reason for infection, 
with Multi-Locus Sequence Typing (MLST) attributing raw chicken as a source in 57-78% of 
cases (26-30). Our study has collected isolates from patients in Basel over four years, 
analyzing whole genome sequences and comparing them to those from potential infection 
sources: local shop-bought raw chicken, frozen meat for “fondue chinoise” (broth fondue), 
river water, pets, raw milk, and livestock. Our preliminary analysis of 685 genomes, from 
patients and chicken meat from 2015-2018, shows a large diversity of isolates across 24 clonal 
complexes. We are most interested in transmission clusters, i.e. patient isolates, which are 
closely related to those from chicken meat. To identify these, we used a hierarchical approach, 
first clustering isolates using core genome MLST ((31); https://pubmlst.org/campylobacter/), 
then looking within these clusters using a whole genome single nucleotide polymorphism 
(SNP) approach. Using a SNP cutoff of 12, which was determined as encompassing the vast 
majority of cases and representing a plausible mutation rate across three years, we can 
identify 20 transmission clusters including only 14% of cases. This preliminary work indicates 
that whole genome studies provide a much higher resolution than those using MLST, and that 
there remain alternative, as yet unidentified infection sources, potentially responsible for up to 
86% of campylobacteriosis cases.  
 
Outbreak investigation of Salmonella spp. in Switzerland (Guido Bloemberg) 
In Switzerland, approximately 1500 human cases of salmonellosis are annually reported to 
the Federal Office of Human Health (32). Salmonella is usually transmitted to humans through 
contaminated food or water. Recognition of outbreaks is highly relevant for source 
identification and effective containment (incl. product recalls). Up to 2018, Salmonella 
outbreaks were monitored using PFGE analysis of suspicious outbreak isolates. During 2018, 
WGS, as most discriminative typing tool, was implemented for Salmonella outbreak analyses. 
Meanwhile, several Salmonella outbreaks have been discovered, are being monitored or/and 
were solved by WGS analysis. In the presentation five examples of Salmonella outbreak 
analyses were presented. Two small outbreaks of S. Typhi (family outbreak after visiting 
Bangladesh) and S. Paratyphi B var. Java (4 patients) were identified in 2018 and 2019, 
respectively. Furthermore, S. Enteritidis cases identified during July-September 2018 were 
systematically analysed by WGS in order to analyse the clonality of the isolates. The results 
showed a large diversity of S. Enteritidis strains with only a few small outbreaks and travel as 
main risk factor. Lastly, we are monitoring two ongoing outbreaks of S. München (38 patients) 
and S. Derby (20 patients) occurring since December 2018 and January 2019, respectively.  
 
Transmission of ESBL-producing E. coli in Basel (Sarah Tschudin-Sutter) 
Community reservoirs have been suggested as being an important driver for the rapid 
emergence and spread of ESBL-producing E. coli. The food chain may represent a potential 
community-source with over 90% of chicken meat  being contaminated with ESBL-producing 
E. coli (33, 34) and almost 20% of healthy Swiss fattening pigs are shedding ESBL-producing 
E. coli (35). 39% of ESBL-producing isolates detected in retail meat samples belonged to E. 
coli genotypes also present in human samples suggesting transmission (34). ESBL-producing 
E. coli  has been identified on 12% of cutting boards and 50% of gloves after poultry 
preparation, pointing to a potential transmission-pathway (36). Both human and animal 
intestinal carriage of ESBL-producing Enterobacteriaceae result in their release into the 
wastewater system. ESBL- producing E. coli have been recently identified in almost all 
environmental samples collected throughout a wastewater network in France, with treatment 
at the wastewater plant resulting in a relative enrichment of ESBL-producing E. coli in the 
sludge, which is consecutively used as fertilizer (37) thereby accelerating further 
dissemination. In Basel, we are currently determining migration of ESBL-producing 
Enterobacteriaceae between humans and their environment (i.e. foodstuffs and wastewater 
samples) by comparing genetic relatedness of strains recovered from patients and the 
environment as part of a NRP72 research project (http://www.nfp72.ch/) (38). 
 
Session IV: Transmissions from the environmental and animals to humans 
In the fourth session various examples of environmental and zoonotic pathogen transmission 
were discussed. First, Prof. Endimiani reported on the current situation of Carbapenem 
resistant Enterobacteriaceae and a NRP72 project, which aims to understand the transmission 
dynamics of Carbapenemase-producing Enterobacteriaceae. Then, Prof. Perreten reported 
on increasing cases of Carbapenemase-producing Enterobacteriaceae found in pets. Next, 
Prof. Schrenzel focused on new technologies – using metagenomic approaches – and 
showcased the impact of this technology in three cases from clinics. Finally, Prof. Greub 
reported on the genomics of Chlamydia-related bacteria. 
 
Carbapenemase-producing Enterobacteriaceae in humans (Andrea Endimiani) 
The prevalence of carbapenem-resistant K. pneumoniae and E. coli strains in Europe reached 
7.2% and 0.1%, respectively; however, only 50-60% of them produce carbapenemases 
(CPE). Most of the CPE responsible for community-onset infection are actually health-care 
associated. This phenomenon may contribute to the expansion of CPE in the community. In 
Switzerland, 1.8% of the human K. pneumoniae isolates are carbapenem resistant. Until 2018, 
CPE were not reported in pets, wild/food animals, and retailed meat. Moreover, CPE were not 
isolated in healthy people, but sporadic strains were reported in returning travelers, 
rivers/lakes, and imported vegetables. 
During the first year of our NRP72 project, we analyzed 29 carbapenem-resistant 
Enterobacteriaceae of human origin using WGS. Strains were from hospital and community 
settings and causing infection or colonization. Of particular interest is the finding that 
veterinary clinic employees can be colonized at gut level with the same CPE (OXA-181-
producing E. coli ST410) responsible for an outbreak among hospitalized pets. Moreover, at 
national level OXA-181 producers are increasing; therefore, an accurate WGS analysis is 
ongoing for different species carrying such resistance gene. The final aim of our work is to 
analyze the exchange of MDR organisms and/or plasmids among the different human and 
non-human settings.        
 
Carbapenemase-producing Enterobacteriaceae in animals (Vincent Perreten) 
Carbapenems are not used in food-producing animals in Switzerland. However, these last-
line antibiotics of human medicine may be used in companion animals for the treatment of 
infections refractory to any other antibiotics used in veterinary medicine (Ordinance on 
Veterinary Medicinal Products, SR 812.212.27, Art. 6, (39)). NGS used during a surveillance 
project financed by the Swiss Federal Food Safety and Veterinary Office [FSVO Grant no. 
1.18.10]a revealed the presence of a nosocomial clone of E. coli containing a plasmid-
mediated carbapenemase. Additionally, cases of infections caused by carbapenemase-
producing Klebsiella pneumoniae have also emerged in our country in companion animals. 
Although NGS allowed the identification of specific carbapenemase-producing clones, further 
additional molecular epidemiology studies are now necessary to determine the link between 
the carbapenemase-producing Enterobacteriaceae from companion animals and those from 
humans. Nevertheless, infection control and monitoring of carbapenemase-producing 
Enterobacteriaceae should be introduced in veterinary settings. 
 
aFSVO project no. 1.18.10 (Simone Schuller, Department of Clinical Veterinary Medicine, 
University of Bern, Bern, Switzerland; Barbara Willi, Clinic for Small Animal Internal Medicine, 
University of Zurich, Zurich, Switzerland; Stefan Kuster, Division of Infectious Diseases and 
Hospital Epidemiology, University and University Hospital of Zurich, Faculty of Medicine, 
Zurich, Switzerland; Andrea Endimiani, Institute for Infectious Diseases, University of Bern, 
Bern, Switzerland; Stefanie Gobeli and Vincent Perreten, Institute of Veterinary Bacteriology, 
University of Bern, Bern, Switzerland) 
 
Unusual zoonoses: the contribution of NGS (Jacques Schrenzel) 
In some instances, the infectious source of severely infected patients remains unknown, 
prompting the physician to perform numerous tests, including radiological investigations. We 
report two such cases: the first one was a bacteremia due to an unusual Capnocytophaga 
canis, most likely transmitted from the patient’s cat. Genomics revealed that this bacterium 
was distantly related to Capnocytophaga canimorsus, and hence could not be detected by 
MALDI-TOF MS. The second case was a septic shock with multiple organ failure due to 
Streptococcus suis. Genomic analysis revealed that the strain was markedly different from 
those recovered from Swiss pigs. The history of the patient ultimately revealed that she had 
eaten raw pork imported from Moldavia, two days before admission. The last case, analyzed 
by our metagenomic platform showed a prosthetic aortic infection due to Mycobacterium 
chelonae, an organism that could not be detected by conventional cultures nor by broad-range 
16S rDNA PCR. The origin of the infectious organism and its relationship with the bovine aortic 
prosthesis are currently under investigation. Overall, these three cases illustrate various 
usages of genomics and clinical metagenomics to uncover bacterial causes of some infections 
and provide molecular hints to explain their acquisition.        
 
Genomics of Chlamydia-related bacteria (Gilbert Greub) 
In the last talk of the day, Prof Greub (Lausanne) presented the lessons gathered from 20 
years of genomics of chlamydia and chlamydia-related bacteria. Chlamydia are important 
zoonotic and veterinary pathogens. Indeed, although Chlamydia trachomatis – the most 
studied member of the Chlamydiales order – is sexually transmitted from human to human, 
Chlamydia psittaci is a well-established pathogen transmitted from birds to humans, which 
has recently been identified in horses as well (40). Chlamydia abortus, a major cause of 
abortion in sheep and goats – has been shown to cause miscarriage in humans exposed to 
infected cattles. Thus, genomics may be pivotal to track outbreaks and to define the virulome 
and resistome of chlamydiae. The Greub’s talk however showed that genomics may go behind 
typing, virulome and resistome analyses, providing insight on the evolution, biology and 
biodiversity of chlamydia-related bacteria. The metagenomics data that have been recently 
released demonstrates the huge biodiversity of Chlamydiales bacteria (41). This biodiversity 
reflects the variety of ecological niches, which include amoebae  (e.g. Parachlamydia, 
Criblamydia, Estrella), mammals (e.g. Chlamydia felis, Chlamydia abortus, Waddlia), fish (e.g. 
Clavochlamydiaceae, Piscichlamydiaceae), birds (e.g. C. psitacci, C. ibidis), reptiles (e.g. 
Parachlamydia), and arthropods (e.g. Rhabdochlamydiaceae). The latter family infects ticks 
with very high burden, suggesting a high transmission risk.  Genomics of all these new clades 
led to identify interesting features, not present in C. trachomatis, including a CRISPR system 
(in Protochlamydia neagleriophila), large number of transposases (especially in Waddlia) and 
a DNA conjugative transfer system (in various chlamydia-related bacteria) demonstrating the 
high genetic plasticity of chlamydial genomes. Genomics of chlamydia-related bacteria also 
highlighted the conservation among all Chlamydiales of some virulence factors, involved in 
cell host corruption (e.g. T3SS system, CPAF) and the presence of specific virulence factors 
such as catalases in some species, likely implicated in the survival of these strict intracellular 
bacteria to the superoxydes produced by amoebae and macrophages.     
 
 
  
Discussions and conclusions  
The symposium brought together “One Health” leaders from Switzerland representing various 
backgrounds including federal offices with public health experts, legal and ethical experts, 
microbiologists, infectious disease specialists, and epidemiologists. Next generation 
sequencing technologies were broadly discussed along with concrete cases from clinics and 
applied and basic research showing the potential to gain a more profound understanding of 
transmission routes between humans, animals, food, and the environment.  
 
Although new sequencing technologies and applications such as metagenomics rapidly move 
forward in research, the usage of these technologies for public health aspects was still 
somewhat controversial discussed in the presence of all stakeholders. Without doubt, today 
WGS provides the highest possible resolution for typing pathogens for either surveillance or 
single outbreak investigations. However, the usage of the technology in public health and 
routine diagnostics is still associated with high costs and requires specific trained experts such 
as bioinformaticians, for proper data interpretation. In addition, the full potential of the 
technology is not yet used: while comparison of pathogens is standard, information on 
resistance genes and virulence factors is often not generated due to lack of curated and 
standardized databases. Finally, the gain of resolution using WGS can provide “unexpected” 
results, where certain isolates may appear connected (or unconnected) supporting or refuting 
classical epidemiological typing. This raises the question of how to best combine whole 
genome sequencing data with data on epidemiological observations to draw meaningful 
conclusions regarding the dissemination and spread of target pathogens – maybe even allowing 
to establish causal inference. These discussions underline our recent exposure to these new 
technologies, while our background remains tightly linked to classical epidemiological tools. 
The expectation on what sequencing should deliver in the near future and how such results 
might impact public health actions somewhat vary between federal institutions and the 
diagnostic community. The discussions highlighted two possible scenarios for epidemiological 
analysis:  
(i) Use of WGS to confirm an outbreak. A (pre-)selected group of isolates with available 
classical epidemiological data e.g. symptoms, exposure, time and space association of 
isolates etc. are analyzed retrospectively using a high-resolution method. Such very 
targeted usage and potential batch-wise sequencing analyses provide a high cost-
efficiency. However, non-outbreak associated controls are also important in outbreak 
investigations, allowing to make comparison to groups and allow to calculate odds ratios, 
which remain the main factor of causal inference. The obvious disadvantage is the 
introduction of a clear bias due to the selection of cases, which may hinder broader 
conclusion on the “big picture”. Whereas in a potential nosocomial cluster investigation 
e.g. based on similar antibiotic resistance profiles, WGS typing can be rapidly 
introduced, in other public health settings a delay in producing sequencing may results 
may be introduced due to a more complex reporting between various institutions.  
(ii) Use of WGS as a real-time surveillance tool. Isolates are sequenced immediately, in a 
less biased way, and directly grouped based on genomic similarities. Based on 
molecular evidence, a detailed classical epidemiological investigation may be triggered. 
This approach may be particular useful when unsuspected molecular epidemiological 
links are discovered and are then followed up using classical epidemiological 
approaches. This strategy may result in significant faster responses for the identification 
of connected cases. However, at least for the coming years, this approach incurs higher 
costs as many more isolates would need to be sequenced.  
Both approaches have obvious advantages and disadvantages, which need to be further 
explored with investigations on specific scenarios and pathogens. For our community, it is 
therefore crucial to learn from these new technologies, not only in tightly controlled 
experimental research conditions, but also in the real-world of public health. Both approaches 
need to be explored and tested in different scenarios and order to define the specific 
advantages. Independently of which approach is preferred, the distribution of molecular and 
epidemiological information to laboratories, policy makers, and public health experts is 
essential. 
 
Data access and sharing, especially of demographic and epidemiological data, is often critical 
in order to use the synergistic potential of classical and molecular epidemiology. In this regard, 
regulations, legal and ethical considerations were discussed. The experts agreed that public 
health questions may be complex and sometimes there are overlaps between public health 
and research objectives. In order to understand the impact of a new technology, data has to 
be analyzed using state-of-the-art research methodologies. Public health investigations 
benefit from timely reporting and dissemination of results – classically this is performed on 
data from mandatory notification (high sensitivity, but low specificity for an outbreak) – 
however given current technological advances sequencing information is now expected to 
provide highly specific data. Molecular surveillance also provides a high sensitivity in contrast 
to targeted outbreak investigation. Pragmatic solutions should be developed for the sharing of 
classical and molecular epidemiology information by carefully addressing the special needs 
of the different stakeholders. The legal framework provides the basis for what information can 
be shared in which situation. The epidemic act provides the legal basis to share information 
at the governmental level (federal and cantonal) but not with the private sector, which induces 
a series of practical challenges for management of transmission events. In the case of an 
immediate public health threat e.g. a new pandemic influenza virus, the epidemiological act 
provides a more clear legal basis. Although also research can be performed under the 
epidemic act, the separation to the human research act has to be further discussed with legal 
and public health experts. Whereas in the case of a research related question, the Human 
Research Act constitutes the legal basis.  
 
In summary, it became clear, that the various experts attending symposium are keen and 
highly motivated to further develop the concepts and knowledge on sequencing for public 
health and One Health. In a small country like Switzerland, the development of a molecular 
surveillance platform integrating the different needs and aspects of the identified stakeholders 
can be developed in as a research project and later scaled up to fit various needs with 
increasing complexity such as specific public health needs. The symposium clearly showed 
that the state-of-the-art infrastructure e.g. sequencing machines, computational clusters, the 
bioinformatic, legal and ethical expertise for a responsible usage of the technologies is in 
place. Several research projects showcased the feasibility and the potential impact, as well as 
the benefits for humans, animals and the environment. What is now needed is the willingness 
and the political support to fill the gaps and scale up.  
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